Connect with us

Now

The Antiviral Drug to Help End COVID-19

Published

on

Avigan

Being stuck in the house for around a month now, the Egyptian citizens let alone the entire globe is getting quite restless. All places that include any socializing are still shut down plus the curfew in Egypt has been extended for another two weeks to ensure safety.

Which is why, you would be happy to hear that Khaled Abdel Ghaffar, the Minister of Higher Education and Scientific Research, has thankfully found a way to communicate with the Japanese manufacturer of the antiviral drug that is claimed to be the cure against the Coronavirus pandemic.

Avigan, the Japanese drug, has been developed by the Fujifilm Holdings Corporation and has been stored in the country for a while now to treat influenza. It has been proved by reports that Avigan has shown quite effective when treating COVID-19 and fighting the respiratory disease specifically that has been caused by the virus.

Fujifilm Holdings Corporation has announced late last night that it will commence phase two of their clinical trials on patients suffering in the United States since their situation has gotten quite out of hands.

Not just that, but our minister has added that Egypt will be joining this scientific research in hopes of finding a medication to truly put an end to the this cruel pandemic.

The trial will admit 50 coronavirus infected patients in collaboration with the Women’s Hospital, Brigham, and the University of Massachusetts Medical School.

 It was also stressed by Dr.Abdel Ghaffar that our President Abdel Fattah el Sisi has crucially instructed a follow up and constant collaboration on a day to day basis with the Japanese Pharmaceutical company to commence manufacturing Avigan in one of the Egyptian pharmaceutical companies located in the City of 10th of Ramadan.

The drug had already been tested on the Japanese citizens when Fujifilm had announced on March 31 the start of phase 3 of the clinical trial.

 

We would like to thank Japan for offering help to end the global pandemic by willing to provide at least 20 countries with Avigan for free. Not just that, but they will be providing the United Nations Office for Project Services $1 million grant to distribute as well as buy the drug.

 

Now

AstraZeneca COVID-19 vaccine Shows 90% Effectiveness With No Serious Side Effects

Published

on

By

AstraZeneca announced today the effectiveness of its Covid-19 vaccine and it turned out to be around 90% effective with no serious side effects!

According to data from the late-stage trials in Britain and Brazil, the vaccine, which is developed by Oxford University, has shown 90% effectiveness after being administered as a a half dose followed by a full dose at least one month apart.

“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” Pascal Soriot, Astra’s chief executive, said in a statement.

British Prime minister Boris Johnson said it was “incredibly exciting news the Oxford vaccine has proved so effective in trials.”

The next step now is for the company to start preparing regulatory submission of the data to authorities across the world that have a framework in place for conditional or early approval.

It will also seek an emergency use listing from the World Health Organization (WHO) to speed up availability in countries with low income. In parallel, the full analysis of the interim results is being submitted for publication in a peer-reviewed journal.

With both Oxford’s and Pfizer’s vaccines, we can be hopeful that the new year will come bearing good news!

Continue Reading

Now

Another Coronavirus Vaccine By Moderna Shows 94.5% Effectiveness!

Published

on

By

Yet another promising news for a Covid-19 vaccine has been announced! Moderna said today that its vaccine has shown 94.5% effectiveness in preventing the virus, according to an analysis of its clinical trial.

The biotech company made the announcement earlier today, giving us a dash of hope amidst this coronavirus scare.

The news follows the announcement made by Pfizer and BioNTech, who said their vaccine was more than 90% effective.

The results come from interim analyses of intensive clinical studies. The clinical trials of Moderna saw the participation of 30,000 volunteers. Half got two doses of the vaccine 28 days apart, half got two shots of a placebo on the same schedule.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stéphane Bancel, chief executive officer of Moderna, in a statement.

Both companies used the same technology in making the vaccines, which is a tech based on a molecule known as mRNA, or messenger RNA. That molecule contains genetic instructions for making proteins inside cells.

We hope that by the end of this year, we can rest assured that a vaccine can soon end this pandemic.

Continue Reading

Now

Hopes Rise As Pfizer Announces That Its COVID-19 Vaccine is 90% Effective

Published

on

By

Hope rises as pharmaceutical giant Pfizer announced that its COVID-19 vaccine has successfully prevented 90% of the virus, a promising result that exceeded experts’ expectations!

This analysis is based on 94 cases of infection with SARS-CoV-2, the virus responsible for causing COVID-19, among both the vaccinated and placebo groups. The results included data from 38,955 of the total 43,538 volunteers who enrolled.

This makes Pfizer the very first company to release results from its Covid-19 vaccine, these findings are a result of collected seven days after the second of Pfizer’s two-shot regimen.

 

 

Continue Reading
Event calender
Cinema calender

Cinema calender

Facebook

Fashion

Categories

Top Posts

Trending

X